250 related articles for article (PubMed ID: 19544202)
21. Pentraxin 3 and C-reactive protein in severe meningococcal disease.
Sprong T; Peri G; Neeleman C; Mantovani A; Signorini S; van der Meer JW; van Deuren M
Shock; 2009 Jan; 31(1):28-32. PubMed ID: 18650775
[TBL] [Abstract][Full Text] [Related]
22. Pregnancy-associated plasma protein-A and C-reactive protein levels in pre-eclamptic and normotensive pregnant women at third trimester.
Deveci K; Sogut E; Evliyaoglu O; Duras N
J Obstet Gynaecol Res; 2009 Feb; 35(1):94-8. PubMed ID: 19215554
[TBL] [Abstract][Full Text] [Related]
23. Changes in the maternal serum concentration of proearly placenta insulin-like growth factor peptides in normal vs abnormal pregnancy.
Bruni L; Luisi S; Ferretti C; Janneau JL; Quadrifoglio M; Richon S; Dangles-Marie V; Bellet D; Petraglia F
Am J Obstet Gynecol; 2007 Dec; 197(6):606.e1-4. PubMed ID: 18060948
[TBL] [Abstract][Full Text] [Related]
24. Raised maternal serum cystatin C: an early pregnancy marker for preeclampsia.
Thilaganathan B; Ralph E; Papageorghiou AT; Melchiorre K; Sheldon J
Reprod Sci; 2009 Aug; 16(8):788-93. PubMed ID: 19436062
[TBL] [Abstract][Full Text] [Related]
25. Maternal serum endostatin at gestational weeks 16-20 is elevated in subsequent pre-eclampsia but not in intrauterine growth retardation.
Wathén KA; Ylikorkala O; Andersson S; Alfthan H; Stenman UH; Vuorela P
Acta Obstet Gynecol Scand; 2009; 88(5):593-8. PubMed ID: 19308751
[TBL] [Abstract][Full Text] [Related]
26. Maternal serum inhibin-A and activin-A levels in the first trimester of pregnancies developing pre-eclampsia.
Spencer K; Cowans NJ; Nicolaides KH
Ultrasound Obstet Gynecol; 2008 Oct; 32(5):622-6. PubMed ID: 18816493
[TBL] [Abstract][Full Text] [Related]
27. First trimester maternal serum placental protein 13 for the prediction of pre-eclampsia in women with a priori high risk.
Khalil A; Cowans NJ; Spencer K; Goichman S; Meiri H; Harrington K
Prenat Diagn; 2009 Aug; 29(8):781-9. PubMed ID: 19418482
[TBL] [Abstract][Full Text] [Related]
28. Low plasma HLA-G protein concentrations in early gestation indicate the development of preeclampsia later in pregnancy.
Yie SM; Taylor RN; Librach C
Am J Obstet Gynecol; 2005 Jul; 193(1):204-8. PubMed ID: 16021080
[TBL] [Abstract][Full Text] [Related]
29. Clinical features of fetal growth restriction complicated later by preeclampsia.
Mitani M; Matsuda Y; Makino Y; Akizawa Y; Ohta H
J Obstet Gynaecol Res; 2009 Oct; 35(5):882-7. PubMed ID: 20149036
[TBL] [Abstract][Full Text] [Related]
30. Adhesion molecules (VCAM-1 and ICAM-1) and C-reactive protein in women with history of preeclampsia.
Portelinha A; Belo L; Tejera E; Rebelo I
Acta Obstet Gynecol Scand; 2008; 87(9):969-71. PubMed ID: 18720045
[TBL] [Abstract][Full Text] [Related]
31. Excess syncytiotrophoblast microparticle shedding is a feature of early-onset pre-eclampsia, but not normotensive intrauterine growth restriction.
Goswami D; Tannetta DS; Magee LA; Fuchisawa A; Redman CW; Sargent IL; von Dadelszen P
Placenta; 2006 Jan; 27(1):56-61. PubMed ID: 16310038
[TBL] [Abstract][Full Text] [Related]
32. Uterine vein and maternal urinary levels of activin A and inhibin A in pre-eclampsia patients.
Muttukrishna S; Hyett J; Paine M; Moodley J; Groome N; Rodeck C
Clin Endocrinol (Oxf); 2006 Apr; 64(4):469-73. PubMed ID: 16584522
[TBL] [Abstract][Full Text] [Related]
33. Decreased serum levels of kisspeptin in early pregnancy are associated with intra-uterine growth restriction and pre-eclampsia.
Armstrong RA; Reynolds RM; Leask R; Shearing CH; Calder AA; Riley SC
Prenat Diagn; 2009 Oct; 29(10):982-5. PubMed ID: 19582702
[TBL] [Abstract][Full Text] [Related]
34. Maternal C-reactive protein levels are raised at 4 weeks gestation.
Sacks GP; Seyani L; Lavery S; Trew G
Hum Reprod; 2004 Apr; 19(4):1025-30. PubMed ID: 14990546
[TBL] [Abstract][Full Text] [Related]
35. Reduced third-trimester levels of soluble human leukocyte antigen G protein in severe preeclampsia.
Hackmon R; Koifman A; Hyodo H; Glickman H; Sheiner E; Geraghty DE
Am J Obstet Gynecol; 2007 Sep; 197(3):255.e1-5. PubMed ID: 17826409
[TBL] [Abstract][Full Text] [Related]
36. Post-delivery oxidative stress in women with preeclampsia or IUGR.
Kressig P; Beinder E; Schweer H; Zimmermann R; von Mandach U
J Perinat Med; 2008; 36(4):310-5. PubMed ID: 18598120
[TBL] [Abstract][Full Text] [Related]
37. Calprotectin, a marker of inflammation, is elevated in the maternal but not in the fetal circulation in preeclampsia.
Braekke K; Holthe MR; Harsem NK; Fagerhol MK; Staff AC
Am J Obstet Gynecol; 2005 Jul; 193(1):227-33. PubMed ID: 16021084
[TBL] [Abstract][Full Text] [Related]
38. Second trimester amniotic fluid endothelin-1 concentrations and subsequent development of intrauterine growth restriction.
Margarit L; Griffiths AN; Tsapanos V; Tsakas S; Gumenos D; Decavalas G
Eur J Obstet Gynecol Reprod Biol; 2007 Oct; 134(2):192-5. PubMed ID: 17123690
[TBL] [Abstract][Full Text] [Related]
39. [C-reactive protein in women with pre-eclampsia].
Batashki I; Milchev N; Topalovska D; Uchikova E; Mateva N
Akush Ginekol (Sofiia); 2006; 45 Suppl 1():47-50. PubMed ID: 16673658
[TBL] [Abstract][Full Text] [Related]
40. First trimester sex hormone-binding globulin and subsequent development of preeclampsia or other adverse pregnancy outcomes.
Spencer K; Yu CK; Rembouskos G; Bindra R; Nicolaides KH
Hypertens Pregnancy; 2005; 24(3):303-11. PubMed ID: 16263602
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
